The
Common Technical Document (CTD) format is now the required format for all
marketing applications in the U.S., EU, Japan, Canada, and Australia. Clinical
Trial Applications (CTAs), the required format of INDs in most countries, are
required to be in the CTD format. Currently, the U.S. does not require INDs to
be in the CTD format, but rather the traditional format (per regulations in 21
CRF 312.23). However, since all marketing applications are required in the CTD
format, it is more efficient to start the IND in the CTD format. If you use the
traditional format, the IND and all amendment information must be converted to
the CTD format prior to marketing application submission. This conversion time
can impact the timeline for marketing application submission, so why not plan
ahead for a successful marketing application and start the IND in the CTD
format?
Currently, there is no
guidance document to facilitate the transfer or mapping of information from the
IND requirements contained in 21 CFR 312.23 to the CTD format. There is often a
difference of opinion on where information should be stored. This web seminar
will give an overview of the IND requirements and where they can most
effectively “fit” into the CTD requirements for a streamlined FDA review and
building of the IND into a marketing application.
- Describe the CTD and how and why it came into
existence
- Describe the eCTD and basics tools
for eCTD implementation
- Define a style guide and describe
why it’s important for eCTD implementation
- Map the contents of the traditional
IND to the CTD format
- Regulatory Affairs Professionals
- Research and Development
Professionals
- Manufacturing Personnel
- Clinical Research Professionals
- Medical Writers
Caroline Ritchie, Ph.D., M.B.A.
Click here for complete trainer
biographies
$735
Includes up to 20
participants at one site. All participants (up to 20) are eligible for
“Certificates of Attendance,” and accreditation, provided that accreditation
requirements are met. For groups larger than 20 or for additional sites, please
call +1 781.972.5400 or toll-free in the U.S. 800.856.2556 for pricing.
Note: Due to COVID-19, we understand that most teams cannot currently dial-in together. As such, we are able to offer additional logins at a highly reduced rate. Please contact Barnett Customer Service at +1 781.972.5400 or toll-free in the U.S. 800.856.2556 to register with your additional participants requiring login credentials. Or email Customer Service at: customer.service@barnettinternational.com
Barnett International is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing
pharmacy education. Participants will
receive 1.5 hours (0.15 CEUs) of continuing education credit for full
participation, including the completion of a pre-test, post-test, and program
evaluation. Barnett International will
issue a receipt of completion for earned CEUs within three weeks of program
completion. ACPE#: 0778-0000-20-075-L04-P.
Released: 11/20.
Hold
this course at your company! For more information, contact Naila Ganatra at +1
215.413.2471.